Canopy Growth Stock News

Cannabis stocks reignited Tuesday afternoon after the U.S. Department of Justice announced that it would move to reclassify marijuana as a less dangerous drug. As a result of the breaking news, sever

For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.

The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.

Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administrati

Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ: CGC ) saw their shares rise dramatically yesterday. As InvestorPlace's Shrey Dua reported, President Joe Biden's admin

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug p

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

Pot stocks rally as the DEA moves to reclassify marijuana as a less dangerous drug. Renita Young discusses this as the DEA's proposal needs to be reviewed by the White House Office of Management and B

Cannabis stocks soared nearly across the board this afternoon on news that President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance, a less severe designation

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Cannabis stocks surged on Tuesday afternoon following multiple media reports that the US Drug Enforcement Administration will approve the reclassification of marijuana as a lower-risk drug. The news w

The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use a

Canopy Growth can move ahead with its plans to acquire U.S.-based cannabis companies via Canopy USA. The company, however, won't be able to consolidate the results.

The global cannabis industry and top marijuana stocks are poised for significant growth, driven by increasing legalization and medical use. Furthermore, experts predict a compound annual growth rate o